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Abstract-[‘H]GABA quantitative autoradiography was used to examine the binding kinetics and regional 
distribution of GABA, receptors in rat brain. The regional distribution was compared to that of GABA, 
receptors. At 4”C, [3H]GABA binding to GABA, receptors reached equilibrium within 45 min. The 
association and dissociation rate constants for GABA, binding to outer neocortical layers were 
2.87 5 0.17 x lo5 min-’ M-’ and 0.0966 f 0.0118 min-‘, respectively, indicating a dissociation constant 
of 336 + 40 nM. Saturation binding studies in the same region yielded a dissociation constant for GABA, 
receptors of 341 f 41 nM while that of GABA, receptors was 92 & 10 nM. While the affinities of each 
type of GABA receptor were uniform across brain regions, the maximal number of binding sites for both 
types of GABA receptor varied across regions. The distributions of the two receptors in rat brain were 
different in the olfactory bulb, cerebellum, thalamus, neocortex, medial habenula and interpeduncular 
nucleus. Areas high in GABA, binding included the medial and lateral geniculates, the superior colliculus 
and certain amygdaloid nuclei. Binding to white matter tracts and ventricles was negligible. 
The distribution of GABA, receptors was in agreement with previously postulated sites of action of 
baclofen. 
Much evidence supports the existence of at least two 
classes of receptors for the inhibitory amino acid 
neurotransmitter GABA.“,25.27 These pharmacologi- 
cally and physiologically distinct classes of GABA 
receptors have been termed the GABA, and GABA, 
receptors. Several agonists selectively activate GABA, 
receptors, including muscimol,67 isoguvacine42 
and 4,5,6,7- tetrahydroisoxazolo[5,4-clpyridin - 3 - 01 
(THIP).‘* To date, baclofen (Lioresal, p-chloro- 
phenyl GABA) is the only known agonist selective for 
GABA, receptors. ‘2~14 GABA, receptors have tradi- 
tionally been characterized by their sensitivity to 
blockade by the GABA antagonist, bicucu11ine,46 
while GABA, receptors are by definition bicuculline- 
insensitive.” Both types of GABA receptors cause 
inhibition, but activate different ionic mechanisms.26 
GABA, receptors are coupled to the benzo- 
diazepine/barbiturate receptor-linked chloride chan- 
nel.35.55.79 GABA, receptors have been associated with 
an inhibitory GTP-binding protein2 and adenylate 
cyclase activity. 3.4’.83 In hippocampal pyramidal neu- 
rons, GABA, receptor activation is associated with 
an increased outward potassium conductance2,32.43 or 
a calcium-dependent potassium conductance.’ The 
effect of baclofen on dorsal root ganglion neurons, 
however, is a direct decrease in calcium conduc- 
tance.23.26 
GABA receptor autoradiography also indicates 
that these two receptors have distinct anatomical 
*To whom correspondence should bc addressed. 
Abbreviation: THIP, 4,5,6,7-tetrahydroisoxazolo[5,4-c]py- 
ridin-3-01. 
distributions’3.‘5,35 within certain brain and spinal 
cord regions. In this report, we describe the kinetic 
properties of GABA, receptors and their regional 
distribution in rat brain as measured by quantitative 
autoradiography using [3H]GABA. A comparison of 
the relative affinities and number of GABA, and 
GABA, binding sites in various brain regions is 
presented. The characterization of these receptors in 
normal rat brain in the present study has enabled us 
to examine their regulation after various experimen- 
tal lesions” and to investigate their status in normal 
and pathologic human brains.“.18 
EXPERIMENTAL PROCEDURES 
Materials 
[‘HIGABA (57 or 71.5 Ci/mmol) was obtained from 
Amersham Inc. (Arlington Heights, IL). Isoguvacine was 
purchased from Cambridge Research Biochemicals Cam- 
bridgeshire, U.K.). The racemic mixture of baclofen was 
donated bv Ciba-Geigv Pharmaceuticals (Suffern. NY). 
Non-radioactive GABA was purchased from Sigma Chem- 
icals (St. Louis, MO). 
Tissue preparation 
Male Sprague-Dawley rats (Spartan Sprague-Dawley) 
weighing 200-250 g were decapitated. Their brains were 
rapidly dissected and frozen over powdered dry ice. Brains 
were mounted with embedding matrix onto cryotome 
chucks and were allowed to thermoequilibrate in the 
cryostat at -20°C. Serial brain sections (20-pm-thick, in 
the horizontal or coronal plane) were cut on a Lipshaw 
cryotome at -20 to - 15°C. The section thickness of 
20pm affords preservation of optimal tissue integrity 
through the various rinse procedures. The latent images 
generated on tritium-sensitive film represent emissions 
arising 5 pm or less from the tissue surface75 and thus, at 
NSC 34,2-D 341 
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20pm, variations in the thickness of the sections do not 
affect the density of the autoradiographic image.” 
The tissue sections were placed on microscope slides 
previously coated with chrome-alum gelatin. These sections 
were then thaw-mounted onto the slides over a warming 
plate. Tissue sections thus obtained were subjected to a 
15 min prewash in 50 mM Tris-HCI buffer containing 
2.5 mM CaCI, (pH 7.40) at 4°C. Slides were then removed 
from the buffer and dried under a stream of cool air. 
[jH]GABA quantitative autoradiography 
[jH]GABA was used to study both GABA, and GABA, 
receptors. GABA, receptors were examined with [‘HIGABA 
in the presence of 10 PM isoguvacine, an agonist which 
specifically occupies GABA, binding sites. Conversely, 
GABA, receptors were assayed with [)H]GABA in the 
presence of IOOpM (&)baclofen. The concentrations of 
baclofen and isoguvacine needed to block binding to either 
GABA, or GAB& receptors, respectively, were determined 
in seoarate inhibition exneriments. Non-soecific I’HlGABA 
binding was determined-by the inclusion bf lOO;i isogu- 
vacine and 100 PM (+)baclofen. Unless otherwise indi- 
cated, assay conditions for both GABA, and GABA, 
binding sites involved a 45 min incubation at 4’C with 
[‘HIGABA in 50 mM Tris-HCl + 2.5 mM CaC& (pH 7.40). 
Slides were placed in vials containing the radioligand-buffer 
mixture. After incubation slides were individually removed, 
subjected to three rapid squirts with buffer followed by one 
quick rinse with 2.5% glutaraldehyde in acetone and imme- 
diately blown dry with warm air. This rinse-and-dry proce- 
dure was completed within 15 s. The slides were mounted in 
an X-ray cassette and apposed to a sheet of tritium-sensitive 
Ultrofilm-‘H (LKB) for 3 weeks at 4°C. After that time, the 
films were developed in Kodak Dl9 for 3 min at 25“C, fixed 
and dried. The films were placed in a photographic enlarger 
and optical densities in various regions of the film were 
quantified using computer-assisted microdensitometry with 
a spot densitometer. 22 Twenty to twenty-five readings 
from each region of interest on each section were averaged. 
Optical densities in various regions of interest were 
quantified in units of pmol of [‘HIGABA bound/mg protein. 
These values were obtained by comparing film densities of 
the brain regions with those generated by W-embedded 
plastic standards which had previously been calibrated 
against brain paste standards containing known amounts of 
tritium and protein.65 The relationship between the amount 
of radioactivity and the optical density was described by a 
computer-generated fourth order polynomial function. 
Determination cf kinetic constants 
Separate experiments to study the association and disso- 
ciation of [‘H]GABA to GABA, receptors were conducted 
using fou; animals for each study. To investigate the 
association of I’HlGABA (19.48 nM. 57 Ciimmol) to 
GABA, sites, ‘tissues sectibns were incubated ‘with 
[‘HIGABA for increasing periods of time ranging from 30 s 
to 120 min. Non-specific binding, assessed by the inclusion 
of 100 PM (k)baclofen, was determined in adjacent sec- 
tions for each time point examined. The assay medium 
also contained 10 p M isoguvacine to prevent binding of 
[‘HIGABA to GABA, sites. For the determination of 
dissociation rate constants, binding of [‘HIGABA (24 nM, 
71.5 Ci/mmol) under GABA,-preferring conditions was 
carried out for 45 min at 4°C. At this point, the dissociation 
of [jH]GABA from GABA, sites was assessed by placing 
slides into large volumes of buffer (method of infinite 
dilution) for varying periods of time ranging from 0 to 
90min. For each time point, non-specific binding was 
determined in an adjacent section. The slides were then 
rapidly rinsed once with 2.5% glutaraldehyde in acetone 
and dried as previously described. Bound values of 
[3H]GABA for both experiments were analysed densito- 
metrically in layers IPI of cerebral cortex. Association of 
[‘HIGABA to GABA, receptors was assumed to obey 
pseudo-first order kinetics. The observed rate constant of 
association (kobr) was obtained from the slope of a plot 
of In(B,/Bc- B,) vs time, where B, was the amount of 
[3H]GABA bound at equilibrium (45 min) and B, was that 
bound at time t. Similarly, the dissociation rate constant 
(k_,) was determined by the slope of ln(B,/E,) vs time, 
where B, was the amount of [“HIGABA bound at 45 min 
and B, was that which bound at various times after infinite 
dilution of label. The association rate constant (k,,) was 
calculated from the following relationship between the 
observed rate constant (kobr) and the dissociation rate 
constant (km,): k,, = (kubs - k_,)/[free GABA]. All slopes 
were calculated by computer-assisted linear regression. An 
equilibrium dissociation rate constant (f$) was determined 
for these data and compared to KD values obtained by 
saturation studies. 
Saturation analyses 
In order to determine affinities (Kn values) and densities 
(B,,, values) of both GABA, and GABA, receptors, satu- 
ration studies were conducted using the method of isotopic 
dilution of [‘HIGABA (5-28 nM, 57 Ci/mmol) with non- 
radioactive GABA. For GABA, receptors, 1OpM isogu- 
vacine was present in all the vials, while 100 hM 
( f )baclofen was added to the GABA, assay medium. The 
range of free I’HlGABA concentrations scanned from 5 nM 
to TpM. Four gnimals each were used for GABA, and 
GABA, saturation experiments. Non-specific binding was 
assessed in serially adjacent sections for each concentration 
of free radioactive [‘HIGABA examined. Values of bound 
[‘HIGABA were quantified in several regions of interest: 
sensorimotor cortex, neostriatum, hippocampal dentate 
molecular layer, and cerebellar granule and molecular 
layers. These were used to construct Scatchard plots which 
were analysed by the iterative computer curve-fitting 
program LIGAND (SCAFIT).S9 B,,, and Ko values and 
corresponding Hill coefficients were determined for both 
GABA receptor subtypes. 
Inhibition experiments 
Competition of [‘HIGABA binding by isoguvacine or 
baclofen was investigated in separate series of experiments 
(each n = 4). Isoguvacine competition assays were con- 
ducted in the absence of any baclofen; however, baclofen 
competition experiments were performed in the presence of 
40 PM isoguvacine. Hill plots were constructed to determine 
lcsO values for binding to discrete layers of the cerebellum. 
K, values were calculated according to the equation: 
K, = ~c,,/(l + [GABA]/&). 
Regional distribution of GABA receptor subtypes 
Total GABA, GABA, and GABA, binding sites were 
mapped in serial sections at nine coronal levels of the rat 
brain using [3H]GABA (23 nM, 71.5 Ci/mmol). Values of 
[IH]GABA bound under GABA,- or GABA,-preferring 
conditions were quantified in several regions of interest in 
four animals. As before, non-specific binding was that which 
remained on adjacent sections in the presence of 1OOpM 
isoguvacine and 100 PM (&)baclofen. The corresponding 
tissue sections were stained for Nissl substance with Cresyl 
Violet to identify the structures in the autoradiograms. 
RESULTS 
Kinetics of‘ [3H]GABA binding to bacloj&-sensitive 
GABA, sites in rat brain 
Binding of [‘H]GABA to GABA, sites reached 
equilibrium within 45 min at 4°C (Fig. 1). Preliminary 
studies revealed that GABA, binding at 4°C for 
45 min was identical in all respects to GABA, binding 
GABA, receptors in rat CNS 
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Fig. 1. Association and dissociation curves for [‘H]GABA binding of GABA, receptors in rat cerebral 
cortical layers I-III from a representative animal Association of 13H]GABA (19 nM, 57 Ci/mmol) to 
GABA, receptors for increasing periods of time was studied in rat brain horizontal sections in the presence 
of IOpM isoguvacine to block binding to GABA, sites. Individual serial sections were used for total 
GABA, binding and non-specific binding at each time point examined. Non-specific GABA, binding was 
defined as the amount of [‘H]GABA bound in the presence of 1OO~M (&)baclofen and 100 PM 
isoguvacine. Inset: dissociation of [3H]GABA binding (24 nM, 71.5 Ci/mmol) under GABAs-preferring 
conditions was obtained after attaining equilibrium (after 45 min). Dissociation was initiated by the 
method of infinite dilution of label for varying periods of time (see Experimental Procedures section). All 
bound values were determined by computer-assisted spot densitometry. The kinetic values given in the 
figure represent the mean of four animals. I?,, the amount of 13H]GABA bound to GABA, receptors at 
equilibrium (45 min); B,, the amount bound at time t. 
Table 1. Comparison of B,,, , KD and nu values for GABA, 
and GABA, receptors in various regions of rat brain 
Area GABA, GABA, 
B,, (pm01 GABA bound/mg protein) 
Cerebral cortex 
Layers I-III 4.02 & 0.26 3.53 + 0.26 
Layer IV 4.69 f 0.22 1.87 f 0.24 
Neostriatum 1.36f0.11 0.91 + 0.12 
Dentate gyrus 
Molecular layer 3.97 * 0.13 2.97 f 0.51 
Cerebellum 
Molecular layer 2.64+0.18 3.58 f 0.49 
Granular layer 9.30 + 0.38 1.66 & 1.65 
Cerebral cortex 
Layers I-III 92+ 10 341 & 41 
Layer IV look19 222 f 46 
Neostriatum 70+ 14 313 & 58 
Dentate gyrus 
Molecular layer 139 + 15 462 f 54 
Cerebellum 
Molecular layer 164k26 481 t 35 
Granular layer 119+ 17 458 + 193 
Cerebral cortex 
Hill number (nH) 
Layers I-III 0.98 f 0.02 0.98 + 0.05 
Layer IV 1.08 f 0.09 1.02 * 0.05 
Neostriatum 0.99 + 0.10 0.99 * 0.05 
Dentate gyrus 
Molecular layer 1.00 * 0.05 1.11 kO.03 
Cerebellum 
Molecular layer 1.03 * 0.05 1.09 * 0.04 
Granular layer 1.01 * 0.07 0.95 + 0.10 
Values represent mean + S.E.M. of four animals. 
at 20°C for 20min, with the advantage that non- 
specific binding was greatly reduced at the lower 
temperature. Binding to baclofen-sensitive GABA, 
sites was reversible and displayed association and 
dissociation rate constants within layer I-III of 
cerebral cortex of 2.87 _t 0.17 x 10s/min per M 
and 0.097 Ifr O.O12/min, respectively. These values 
yielded an equilibrium dissociation constant (K,,) of 
336 f 40 nM. This estimate of GABA, affinity was in 
close agreement with the value of 341 f 41 nM for 
cerebral cortex as disclosed by saturation experiments 
(Table 1). Figure 2 shows a typical saturation 
isotherm and the associated Scatchard plot for layers 
I-III of cerebral cortex. 
The binding affinity (Kn) of [3H]GABA for 
GABA, receptors was roughly three- to four-fold less 
than its affinity for GABA, receptors (Table 1). The 
Kr, values of GABA, binding sites in various regions 
of the rat CNS generally ranged from 300 to 500 nM, 
whereas the Kn values of GABA, binding sites were 
within the range of lOCk200 nM. While the affinities 
of GABA, and GABA, receptors were fairly con- 
stant across different brain regions, their densities 
(B,,,,,) varied from region to region. For example, 
within cortical layers I-III there were roughly equal 
numbers of GABA, and GABAA receptors, while 
more GABA, than GABA, receptors were present in 
layer IV. Similarly, the molecular layer of the 
344 D. C. M. CHU e/ ul. 
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Fig. 2. Saturation of GABA, binding sites by increasing concentrations of [3H]GABA in the presence of 
10 PM isoguvacine. The curve shows GABA, binding in cerebral cortical layers I-III from a representative 
normal rat brain. Saturation was achieved by isotopic dilution of [‘HIGABA with known concentrations 
of non-radioactive GABA. Bound values were calculated with appropriate adjustments of the resultant 
specific activity. Inset: Scatchard (Rosenthal) piot of the same data to yield B,,, (x-intercept) and Ko 
(negative reciprocal slope) values. 
cerebellum was enriched in GABA, receptors while 
GABAA receptors were more numerous in the cere- 
bellar granule cell layer. In striatum and dentate 
gyrus, where both types of receptors were found, 
GABA, binding sites accounted for roughly 40% of 
all GABA receptors. The Hill coefficients for both 
GABA, and GABA, binding sites in several regions 
were close to unity (Table I). 
Displacement studies in the cerebellum (Fig. 3) 
demonstrated that a combination of 40 y M isogu- 
vacine plus 100 p M ( + )baclofen was able to displace 
all specific [‘HIGABA binding. These data suggest 
that under these conditions only single populations of 
GAlBAA and GABAs receptors can be distinguished. 
Regional di~trjbut~on qf” GABA, and GABA, binding 
sites in rat brain 
Specific t3H]GABA binding of GABA, and 
GABA, receptors in a number of brain regions is 
shown in Table 2. The distribution of GABA, and 
GABA, binding sites displayed marked heterogeneity 
in some regions, and striking similarity in others, as 
demonstrated in the autoradiograms and correspond- 
ing Nissl-stained sections in Fig. 49. For example, in 
the olfactory bulb, GABA, binding was highest in the 
glomerular layers, whereas GABA, binding occurred 
predominantly in the external plexiform and inner 
granular layers. In several other regions, as exem- 
plified by the geniculate bodies and superior col- 
liculus, the distribution of GABA, receptors 
paralleled that of GABA* receptors. 
[RHIGABA exhibited differential binding to 
GABA, and GABA, sites in various cortical layers 
and lobes. Binding to both types of GABA receptors 
was highest in parietal cortex, followed in order by 
striate, temporal, frontal, retrosplenial, piriform and 
entorhinat cortices. The anterior cingulate cortex 
exhibited greater [3H]GABA binding than did the 
posterior cingulate cortex. In general, binding to 
GABA, receptors occurred in a distinct laminar 
pattern to cortical layers I-IV and Via, while GABA, 
binding was primarily restricted to cortical layers 
I-III. 
With notable exceptions, a consistent finding in 
virtually all brain regions examined was that GABA, 
binding accounted for roughly 70-80% of total 
[‘HIGABA binding, while GABAs binding repre- 
sented 2C&30% (Table 2). Exceptions to this general- 
ization were seen in the medial habenula, the 
glomerular layer of the olfactory buib, the superficial 
gray of the superior colliculus, the interpeduncular 
nucleus, the pontine nuclei, and the molecular layer 
of the cerebellum. These regions exhibited the highest 
levels of GABA, binding, where these receptors 
accounted for as much as 90% of total 13H]GABA 
binding. Other regions exhibiting high absolute val- 
ues of GABA, binding sites were found in various 
cortical and thalamic structures and certain amyg- 
daloid subnuclei (see Table 2). 
Brain regions which exhibited intermediate levels of 
GABA, binding included the external plexiform layer 
of the olfactory bulb, accessory olfactory nucleus, 
lateral septal nuclei, posterior cingulate cortex, ventro- 
lateral and ventromedial thalamus, anterior cortical 
and medial amygdala, the molecular layer of the den- 
tate gyrus, and the granular layer of the cerebellum. 
GABA, receptors in rat CNS 
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Fig. 3. Competition of [-‘H]GABA (16nM, 57Ci/mmol) binding by isoguvacine and (&)baclofen in 
normal rat cerebellum. The solid line represents values obtained from the molecular layer while the dashed 
line represents data obtained from the granule cell layer. Increasing concentrations of isoguvacine compete 
for roughly 40% of total specific [3H]GABA binding sites in the molecular layer and for 90% of total 
[‘HIGABA sites in the granule cell layer. In the presence of 40 PM isoguvacine, increasing concentrations 
of ( f )baclofen effectively compete for the remaining 60% of total specific [3H]GABA binding sites in the 
molecular layer and for 10% of [‘H]GABA binding sites in the granule cell layer. Inhibition constants 
(K, for isoguvacine and baclofen were calculated by the equation: K, = iq,/(l + [GABA]/Ko) where the 
dissociation constants (K,) were obtained by separate saturation studies. The points represent the mean 
of four animals. Standard errors of the mean were not plotted for the sake of clarity. 
Relatively low amounts of binding to GABAB 
receptors (< 0.1 pmol/mg protein) were observed in 
the neostriatum, globus pallidus, hippocampal 
formation, substantia nigra and other brainstem 
regions. GABA, binding to white matter tracts or 
ventricles was indistinguishable from non-specific 
background levels. 
GABA, receptors generally predominated in corti- 
cal, septal and hippocampal regions as well as in 
certain thalamic relay nuclei (VPM and the genicuiate 
bodies). Binding to GABA, receptors was also high 
in the external plexiform layer of the olfactory bulb 
and the granular layer of the cerebellum. Intermedi- 
ate levels of binding to GABA, receptors occurred in 
basal ganglia, basal forebrain, amygdala, thalamus, 
superficial gray of the superior colliculus, central 
nucleus of the inferior colliculus, pre- and para- 
subiculum and the molecular layer of the cerebellum. 
Low amounts of GABA, binding were found in the 
hypothalamus, habenula, mammillary bodies, sub- 
thalamus, substantia nigra, and other midbrain and 
pontine regions. 
DISCUSSION 
Kinetics of [‘H]GABA binding 
The distribution of GABA, receptors as revealed 
by [3H]GABA autoradiography confirms and extends 
the findings of previous autoradiographic and hom- 
ogenate binding studies which have used either 
[3H]( -)baclofen or [3H]GABA as ligands for GABA, 
receptors. ‘2~‘3~15~24~34~42~8i The technique described here 
provides a sensitive assay for dete~ining the affinity 
and number of both GABA, and GABA, receptors 
in anatomically discrete brain regions. 
One concern is whether a component of the ob- 
served [3H]GABA binding sites could represent uptake 
or sequestration of the ligand into membrane-bound 
saccules. However, the specific [3H]GABA binding 
assay used here is unlikely to reflect binding to the 
GABA uptake site for the following reasons. Sodium 
ions, which have been shown to be required for 
[3H]GABA uptake binding in tissue homogenates,“’ 
have been excluded from the assay medium. Further- 
more, a specific antagonist of the GABA uptake site, 
nipecotic acid, did not block any component of 
[3H]GABA binding (unpublished observations). The 
autoradiographic method involves freezing and thaw- 
ing of brain sections-a step which has been shown 
to disrupt membrane-bound saccules.47 The equi- 
librium dissociation constant (Ko) derived by kinetic 
experiments agreed well with the K,, determined by 
equilibrium saturation experiments-a feature of re- 
versible equilibrium binding conditions that is incon- 
sistent with sequestration of label into membrane 
saccules. In addition, all steps in the present assay 
346 D. C. M. CHU et al 
Table 2. Comparative regional distribution of GABA, and 
GABA, binding sites in rat brain 
Area 
Area GABA, GABA, 
Table 2.-cont. 
Olfactory bulb 
External plexiform layer (EPL) 
Glomeruhir layer (Glom) 
Inner granular layer (IGL) 













Anterior cingulate (AC& 
Posterior cingulate (PCg) 
Entorhinal (Ento) 





Lateral septal, dorsal (LSD) 
Lateral septal, ventral (LSV) 
Lateral septal, intermed. (LSI) 
Horizontal diagonal band (HDB) 
Medial septal (MS) 




212&32 79+ I2 
276k61 140+9 
626+76 350f40 










Ventral pallidurn (VP) 
Olfactorv tubercle (Tu) 
Bed nucleus stria terminalis 
medial (BSTM) 
lateral (BSTL) 
Nucleus basalis of Meynert (NBM) 
Deep telencephalic nuclei 
Neostriatum (CPu) 
Nucleus accumbens (NA) 
Globus nallidus (GP) 
Major island of Calleja (MCj) 
Claustrum (Claus) 
Endopitiform nucleus (Endo) 
Amygdala (Amyg) 
basolateral nucleus (BLa) 
lateral nucleus (Latj ’ 
central nucleus (Ce) 
anterior cortical (ACo) 
basomedial nucleus (BM) 
medial nucleus (Med) 
posteromedial cortical (PMCo) 
Hippocampus 
Dentate gyrus 
molecular layer (SMDG) 
granular layer (SGDG) 
CA3 region 
stratum oriens (Or) 
stratum lucidum (Luc) 
stratum radiatum (Rad) 
lacunosum/moleculare (LM) 













479k I7 217+21 
627k80 170+13 
164_f41 75+ 15 
275 k 38 90&22 
178k39 77+23 
297 + 36 I I3 + 25 
278+41 ll2i24 
392 + 69 84+20 
422 & 55 88k 17 
442+61 92&2l 
389&58 102k21 
285 + 25 852 I2 
Parasubiculum (ParaS) 
638 f 84 328 $- 54 
416+51 186*36 
891&98 488+58 
981+84 521 k74 
936 k 102 422 f 35 
957 f 102 360 * 35 
610+80 26Ok23 
708 + 93 230 k 26 
304*50 Ill*11 
765 & 142 335 & 18 




741 k51 335+24 
822 + 58 339 + 23 
343+62 172&24 
312k76 lOOk 
230 + 41 92 + 14 
242 + 29 53 f IO 
240&-50 63+15 
48+12 25k 12 
298 +41 85&22 
308 f 53 55* 14 
I68 & 35 108 + 37 
233 k 47 92*33 
l94*21 52f15 
336 + 62 75&8 
351 k 85 87k 17 
123 + I4 51& 13 
523 k 94 93 & I2 
686 f 92 205 + 28 





Lateral posterior (LP) 
Posterior (PO) 
Dorsolateral geniculate (DLG) 
Ventrolateral geniculate (VLG) 
Dorsomedial geniculate (MGD) 
Ventromedial geniculate (MGV) 
Stria medullaris thalami (Sm) 
Lateral habenula (LHb) 
Medial habenula (MHb) 
Hypothalamus, other 
Medial preoptic area (MPOA) 
Lateral preoptic area (LPOA) 
Septohvpothalamic nucleus (SHv) 
Anterior hypothalamus (AH) . 
Lateral hypothalamus (LH) 
Ventromedial hypothalamus (VMH) 
Posterior hvnothalamus (PH) 
Arcuate nuieus (Arc) ~ ’ 
Medial mammillary body (MM) 
Lateral mammillary body (LM) 
Subthalamus (ST) 
Zona incerta (ZI) 
Midbrain 
Superior colliculus 
superficial grey (SuGr) 
optic nerve layer (ONL) 
intermediate grey (IntGr) 
intermediate white (IntWh) 





234 k 34 60+ 10 
108&ll 31 f 10 
6llk80 497+74 
241+ I6 ll4*7 
278 f 26 96+ I4 
I#& I5 40+6 
252 + IO 76+7 
176k23 43+5 
346+61 93k22 
283 & 17 147 k 30 
21Ok21 110+25 
194&28 92+20 
71* I5 11+7 
127+29 66f II 
217& 13 84+5 
114+ 13 72f 12 
Anterior pretectal nucleus (APT) 
Pretectal nucleus (Pt) 
Dorsal central grev (CGD) 
Central grey (Cc j 
Rostrolinear raphe (RLi) 
Red nucleus (Red) 
Substantia nigra 
pars compacta (SNC) 
pars reticulata (SNR) 
Ventral tegmental area (VTA) 
Other brainstem nuclei 
Inferior colliculus 
central nucleus (CIC) 
Interpeduncular nucleus (IPN) 
Dorsal raphe (DR) 
Parabigeminal nucleus (PBG) 
Cuneiform nucleus (Cn) 
Pontine reticular formation (RF) 
Pontine nuclei (PnN) 
Pontine central grey (PnCG) 
Dorsal parabrachial (DPN) 
Mesencephalic nucleus of V (m5) 
Ventral cochlear nucleus (VCN) 
Cerebellum 
Molecular layer (Mol) 
Granule cell layer (Gran) 
GABA, GABA, 
368k67 216k 19 
567 + IO I 286 + 39 
6llk70 315&47 
84+12 33* 12 
486k46 162k 17 
445&68 137+36 
702k63 207+ 14 
315k73 156&27 
52l+ 108 2Ol+ 21 
313k69 2lOk32 
295+24 176+20 
229 & 37 96+31 
674+ 123 29l& 33 
560 + 63 255 + 29 
853+93 317k40 
150+ I3 701 16 
610&84 317+49 
918k 100 367+49 
178k68 87k36 
88&31 173k 19 
64+30 632+58 
207 k 53 95i.25 
162+28 62k 14 
l45*28 78+26 
192+28 60+16 
102 + 16 41* I2 
234 + 52 94k18 
498+55 144k28 
Ill*21 362+227 
275k61 lO5+ I5 
511+92 57+ IO 
125&8 58 k 14 
59+3 2217 
52k18 56+ 17 
273&9 144+8 
146& 14 106k 19 
477* I88 145+43 
701-15 42k9 
411+27 453+60 
2410& 155 l58k I7 
Values of [‘HIGABA bound (fmol/mg protein) represent 
mean * S.E.M. of four animals. I’HlGABA concentra- 
tion was 23 nM. Autoradiograms were generated and 
quantified as described in the text. 
Fig. 4. Binding at the level of the olfactory bulb. 
Figs 4-9. These figures depict the regional distribution of GABA binding sites in rat brain sections as 
generated by quantitative autoradio~phy using [‘H]GABA (23 nM, 71.5 Ci/mmol). Autoradiograms 
were generated as described in the Experimental Procedures section. All abbreviations are given in Table 
2. Each figure shows [3H]GABA binding to GABA, and GABA, sites in adjacent coronal sections as well 
as Cresyl Violet stained micrograph, in the following manner. (A} GABA, sites as shown by binding of 
[3H]GABA in the presence of 1OOpM (f)baclofen. (B) GABA, sites as shown by the binding of 
t3H]GABA in the presence. of 1OpM isoguvacine. (C) Nissl-stained micrographs of the corresponding 
brain sections. 
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Fig. 6. Binding at the level of the dorsal hippocampus. 
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Fig. 7. Binding at the level of the medial geniculate body. 








Fig. 8. Binding at the level of the inferior colliculus. 
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Fig. 9. Binding at the level of the rostra1 pons and cerebellum. 
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were performed in hypotonic (50mM) Tris buffer, 
which reduces uptake by lysis of membrane-bound 
saccules4’ 
The binding constants obtained in this study were 
consistent with those reported previously for GABAs 
sites in homogenate studies using [3H]GABA54 and 
[3H]baclofen. I3 In the presence of 2.5 mM CaCl, and 
10 PM isoguvacine, Scatchard plots of GABA, bind- 
ing were linear and yielded Hill coefficients close to 
unity. Likewise, [3H]GABA appeared to bind to a 
single GABA, site in the presence of 100 PM 
(f)baclofen. Thus, [‘H]GABA appeared to bind to 
homogeneous GABA, and GABA, receptor popula- 
tions. However, other populations of GABA, and 
GABA, sites demonstrating much lower affinity or 
more rapid dissociation kinetics may have gone unde- 
tected by our assay conditions. 
Using similar ionic conditions, others have shown 
monophasic GABA, binding in tissue homogenates.‘* 
Some studies, however, have resolved two baclofen- 
sensitive [‘H]GABA sites.” [3H]( -)Baclofen itself 
had been shown to bind to a single site in rat 
forebrain sections34 and in rat cerebellar mem- 
branes.24,50 Bowery et a1.l3 have found that 
[3H]( -)baclofen binds to two sites in rat brain mem- 
branes with high and low affinities of 19 and 304 nM, 
respectively. They also describe two baclofen-sensi- 
tive t3H]GABA binding sites with affinities of 29 and 
1242 nM, in contrast to their previous findings of a 
single site. ‘* This discrepancy was attributed to the 
use of excess radioligand (> 10 nM) in the earlier 
study which would have revealed only the low affinity 
site. A higher affinity GABA, site in our assay may 
also have gone undetected, but such a high affinity 
site was investigated by using [‘H]GABA concentra- 
tions from 5 to 20 nM for the lower points in the 
saturation curve. 
Although the GABA, binding site exhibited a KD 
of approximately 300 nM, it displayed rather slow 
association and dissociation kinetics. These two fea- 
tures are not incompatible, as the K,, derived from the 
kinetic experiments agreed very well with K, values 
obtained from saturation studies. The relatively slow 
on and off rates for [3H]GABA may reflect the low 
temperature (4°C) at which the assay was conducted. 
It is unlikely that these values reflect artifactual 
kinetics, as a discrepancy between KD values obtained 
from kinetic and saturation studies would be ex- 
pected in that case. 
Distribution of [3H]GABA binding 
The present study extends previous autoradio- 
graphic descriptions of the localization of GABA, 
and GABA, receptors 15s6~8’ by providing direct quan- 
titative comparison of the affinity and number of 
GABA, versus GABA, receptors in discrete brain 
regions (Tables 1 and 2, Figs 4-9), and by obtaining 
kinetic constants within the same animals using 
quantitative autoradiography (Fig. 1). We also 
report detailed displacement curves for baclofen and 
isoguvacine from data obtained in serial autoradio- 
graphic sections (Fig. 3). 
Our findings are in close agreement with an earlier 
study by Bowery et al. ” However, differences in 
methodology between the present and the earlier 
study should be pointed out. Bowery et a1.‘5 per- 
formed assays in brains fixed by paraformaldehyde 
perfusion. They used IO-pm-thick sections, room 
temperature incubations in hypotonic buffer, brain 
paste standards for calibration of optical densities, 
and reported bound values in pmol/g wet weight 
tissue. Furthermore, KD and B,,,, values were re- 
ported for GABA, and GABA, binding to whole 
brain sections and not from distinct areas of the 
brain. Despite these differences in methods, however, 
the regional localization of GABA, and GABA, 
binding sites demonstrated by our assay is in excellent 
agreement with that of Bowery’s earlier report. 
The general trend apparent from regional distribu- 
tion results is that the ratio of GABA, vs GABA, 
binding at a single concentration of [-‘H]GABA is 
roughly 1: 3-l :4. This ratio may primarily reflect 
differences in receptor affinity, as GABA* receptors 
exhibit three- to four-fold higher affinities for 
[3H]GABA than GABA, receptors (Table 1). Regions 
where differences in receptor number may outweigh 
those in receptor affinity typically exhibit other ratios. 
For instance, in the cerebellar granule cell layer, 
GABA, receptors are four times more numerous 
than GABA, receptors; but in the molecular layer, 
GABA, receptors outnumber GABA, receptors 
(Table 1). 
The greater affinity and apparently greater number 
of GABA, than GABA, receptors in several brain 
regions may account for certain electrophysiological 
observations. Activation of GABA, receptors by 
GABA may be easier to detect in vitro when GABAA 
receptors are masked by bicuculline.32 The differential 
affinity may also contribute to differences in the onset 
of GABA,- vs GABA,-mediated membrane events. 
GABA,-mediated membrane effects are usually 
slower in onset and longer in duration than GABA, 
membrane activation. 32*M) Since GABA, receptors 
have a higher KD than do GABA, receptors, GABA 
released into the synaptic cleft might first interact 
with GABA, receptors. As the amount of GABA 
released into the synaptic cleft accumulates over time, 
GABA, receptor activation could be recruited. The 
difference in time of onset of observable electrophys- 
iological effects of GABA could also be related to the 
slow association time at GABAs receptors and the 
fact that GABA, receptors are coupled to inhibitory 
guanine-nucleotide binding proteins.2 
Table 2 details the existence of GABA, sites previ- 
ously undetected by biochemical, behavioral or phys- 
iological methods. The highest density of GABA, 
sites was found in the medial habenula. It is not clear 
if GABA, receptors in the medial habenula are 
innervated by local interneurons or by an extrinsic 
GABAergic source. Putative extrinsic GABAergic 
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afferents to the medial habenula may come from the 
nucleus of the diagonal band of Broca.‘* Efferent 
projections from the medial habenula innervate the 
interpeduncular nucleus.” The interpeduncular nu- 
cleus has the second highest level of GABA, binding 
in the rat brain. Habenular stimulation has resulted 
in analgesia in animal models of chronic pain.- That 
GABA, receptors are highest in the medial habenula 
and interpeduncular nucleus may correlate with some 
of the analygesic effects of baclofen observed clini- 
ca11y”“,7x and experimentally.7.20~36~s3 However, whether 
baclofen affects transmission along the habenulo- 
interpeduncular tract remains to be investigated. 
Price et al.,” suggested that interpeduncular 
GABA, receptors may exist on presynaptic terminals 
of fasciculus retroflexus afferents from the medial 
habenula. In their study, kainate- or ibotenate- 
induced lesions of intrinsic interpeduncular neurons 
did not cause reductions in GABA, receptor binding, 
while electrolytic habenular lesions result in 85% loss 
of interpeduncular GABA, sites 12 days post-lesion. 
Other brain regions possess GABA, receptors 
whose physiological function is unknown. These in- 
clude the lateral and medial geniculate bodies, vari- 
ous thalamic nuclei and the superior colliculus. These 
regions, however, do exhibit glutamate decarboxy- 
lase-positive reaction product’” and dendrodendritic 
synapsesZ9,” GABA, receptors in these areas could 
be involved in dendrodendritic inhibition. 
In general, GABA receptor distribution parallels 
the topography of glutamate decarboxylase-positive’” 
and GABA-immunoreactive terminals.6J An excep- 
tion to this trend is observed in the globus pallidus, 
where little [3H]GABA binding occurs despite well- 
documented presynaptic markers. This discrepancy 
could in part reflect quenching of tritium label by the 
rich network of white matter tracts which traverse 
this structure.” 
Electrophysiological studies of GABA, receptors 
in the hippocampal slice have shown both pre- and 
postsynaptic effects of baclofen.4~8~M~66 Baclofen 
blocks synaptic transmission across various excita- 
tory hippocampal pathways.s*5’,63 presumably by de- 
creasing presynaptic release of glutamate or 
aspartate. 49 Baclofen completely blocks conduction 
across the CA3-CA1 synapse and partially blocks 
transmission across the medial perforant pathway.5 
Baclofen also directly mediates postsynaptic hyper- 
polarization of hippocampal granule and pyramidal 
cells.6~3’~6”~xo This hyperpolarizing effect of baclofen 
appears to involve an outward barium-sensitive 
potassium current”‘.43 and is more readily elicited 
from the dendritic zones of hippocampal pyramidal 
cells than from the soma.6o 
The high density of GABA, receptors in the CA1 
region and in stratum moleculare of the dentate gyrus 
is consistent with findings that baclofen depresses 
synaptic transmission across the CA33CA1 synapse 
and across the perforant pathway.” Interestingly, the 
presubiculum and parasubiculum demonstrate high 
densities of GABAa binding sites, although ba- 
clofen’s electrophysiological effects in these regions 
have not been documented. Lastly, GABA, and 
GABA, receptor distribution in rat hippocampal 
formation parallels that in human hippocampal 
formation.” 
In a previous study, dendrites and somata of 
granule cells in the external plexiform layer and 
periglomerular neurons in the glomerufar layer dis- 
played dense glutamate decarboxylase-positive im- 
munoreactivity.74 These cells apparently subserve 
dendrodendritic inhibition of mitral and tufted cells 
activity following stimulation of major olfactory 
pathways. “.” In the present study, GABA, receptors 
were present within the external plexiform layer of 
the olfactory bulb. The GABA, antagonists, picro- 
toxin and bicuculline, block dendrodendritic inhibi- 
tion by granule cells6’ Thus, GABA, receptors may 
mediate inhibition of mitral cells by GABAergic 
granule cells. GABAs receptors were present in the 
glomerular layer. ‘although the el~trophys~ology of 
bacfofen and the pharmacology of dendrodendritic 
inhibition by periglomerular cells have not been 
directly examined in the olfactory bulb, a bicuculline- 
resistant inhibitory postsynaptic potential has been 
observed previously in mitral cells following ortho- 
dromic stimulation of the olfactory nerve.45 There- 
fore, we suggest that GABA, receptors may be 
responsible for inhibition of mitral and tufted cells by 
periglomerular neurons. 
Much evidence supports the existence of GABA, 
receptors within the cerebral cortex. Baclofen inhibits 
the release of endogenously incorporated gluta- 
mate,49-hq aspartate4~.“~ and serotonin” from cortical 
slices. Cortical GABA, receptors are decreased after 
lesion of the dorsal adrenergic bundle.48 These data 
suggest that GABA, receptors may exist as presynap- 
tic heteroreceptors on cortical afferents where they 
attenuate release of excitatory amino acids and bio- 
genie amines. GABA, receptors are localized primar- 
ily in outer layers (I-III) of cerebral cortex. The outer 
layers of cortex receive afferents predominantly from 
cortico-cortical association fibers,” which most likely 
use glutamate or aspartate as a neurotransmitter.‘.40 
The laminar distribution of serotonin” and noradren- 
ergic” input to the neocortex is more uniform and not 
confined to the outer layers of cortex. Therefore, if 
cortical CABA, binding sites represent true hetero- 
receptors, they are likely to be largely on glutamater- 
gic cortico-cortical afferents. However, the possibility 
that GABA, receptors may exist on postsynaptic 
intrinsic cortical neurons cannot be disregarded. 
Striatal GABA, receptors are few in number when 
compared to the density of striatal GABA, receptors. 
Baclofen, acting at presumptive presynaptic GABA, 
receptors in the striatum, reduces the evoked 
release of dopamine’” and potentiates the release of 
[Met]-enkephalin from rat striatal slices.76 GABA, 
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receptors may also exist on corticostriatal terminals, 
based on preliminary anatomical lesion data.51 In 
addition, baclofen reduces field potentials evoked by 
stimulation of cortical efferents.21 However, intra- 
cellular recordings from caudate neuronsa have 
shown that systemic or intracaudate baclofen does 
not reduce excitatory postsynaptic potentials in re- 
sponse to cortical or thalamic stimulation, but blocks 
evoked hyperpolarizations. This suggests that ba- 
clofen has no effect upon striatal afferents, but that 
it exerts a direct effect on intracaudate circuitry. 
Thus, baclofen-sensitive GABA, receptors may exist 
on postsynaptic neurons within the striatum. Lesion 
studies from our laboratory indicate that striatal 
GABA, receptors are unchanged after decortication 
but are markedly reduced after striatal ibotenate 
lesions.r9 
The differential laminar localization of GABA, 
and GABA, receptors in the cerebellum confirms 
previous reports.15~8’ We also find the molecular layer 
to be enriched in GABA, receptors, and the granular 
layer to have the greatest density of GABA, 
receptors in rat brain. Studies in mutant mice 
indicate that GABA, receptors in the molecular layer 
of the cerebellum may be localized on Purkinje 
cell dendritesI and on parallel fibers from granule 
cells.” Kato and Fukuda” found that lesions of the 
inferior olive result in decrements of cerebellar 
GABA, receptors and proposed that GABA, 
receptors may exist on climbing fiber afferents to the 
cerebellum. 
CONCLUSION 
The regional distribution and kinetic properties of 
GABA, binding in rat brain are in excellent agree- 
ment with previous GABA, binding studies. The 
distribution of GABA, sites within rat brain corre- 
lates well with sites where baclofen has been shown 
to have biochemical and electrophysiological actions. 
In addition, GABA, sites are highest in the medial 
habenula and interpeduncular nucleus, where they 
may be involved in central pain pathways. 
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